A synthesis of 20 recently added cannabis articles — key themes, clinical context, and Dr. Caplan’s take.
Lynn Silver, MD, MPH, FAAP, warns of psychiatric risks with adolescent cannabis use
WHY IT MATTERS: Parents and young people should understand that cannabis use during adolescence is not a low-stakes decision, because the developing brain processes cannabinoids very differently than an adult brain does, with potential consequences for long-term mental health. CLINICAL OVERVIEW: Adolescent cannabis use carries meaningful psychiatric risks because the developing brain, particularly the endocannabinoid system, is uniquely vulnerable to disruption from exogenous cannabinoids during the years of active neurodevelopment that extend into the mid-twenties. Exposure during this window has been associated with increased rates of anxiety, depression, and psychosis, with higher-potency THC products amplifying these concerns considerably.
Wisconsin Democrats File Bill to Legalize Adult-Use, Medical Cannabis; Regulate Intoxicating Hemp
WHY IT MATTERS: If this bill passes, Wisconsin patients could gain legal access to medical cannabis while a dedicated research fund begins generating state-level data that could eventually inform safer, more evidence-based prescribing guidance. CLINICAL OVERVIEW: Wisconsin Democrats have introduced legislation that would establish a legal framework for both adult-use and medical cannabis in the state, while also creating regulatory guardrails around intoxicating hemp-derived products. A key feature of the proposal is a dedicated excise tax on flower sales that would direct revenue into a Cannabis Research Fund, signaling an intent to pair legalization with scientific inquiry.
Health department providing safe-storage marijuana bags in vending machines – WBAL-TV
WHY IT MATTERS: If cannabis is stored at home without child-resistant containers, even occasional or recreational adult use significantly increases the risk of accidental ingestion and emergency room visits for children in that household. CLINICAL OVERVIEW: Cannabis legalization for adults in Maryland has been accompanied by an unintended consequence seen across many states: increased accidental exposures in children and a rise in cannabis-related emergency visits among both pediatric and adult populations. Proper storage is one of the most evidence-supported harm reduction strategies available, as the majority of pediatric ingestions occur when cannabis products are left accessible in the home.
Major study finds strong link between cannabis, anxiety and depression – Medical Xpress
WHY IT MATTERS: If you are using cannabis to manage anxiety or low mood, this research reinforces the importance of discussing your use openly with a knowledgeable clinician who can help evaluate whether cannabis is helping, harming, or simply co-existing with your mental health symptoms. CLINICAL OVERVIEW: Large-scale observational data from Canadian populations consistently shows that cannabis use and mental health conditions such as anxiety and depression tend to cluster together, but establishing the direction of that relationship remains scientifically complex. Bidirectional associations are well-documented, meaning that some individuals use cannabis to manage pre-existing symptoms while others may experience worsening mood or anxiety as a consequence of use, particularly with high-THC products and frequent consumption patterns.
Modern Cannabis Is Hitting Gen Z Mental Health Hard – Neuroscience News
WHY IT MATTERS: Young people who use high-potency cannabis products frequently should understand that their risk for developing or worsening anxiety and depression is meaningfully elevated compared to non-users or infrequent users, and that risk increases the earlier in adolescence use begins. CLINICAL OVERVIEW: The relationship between high-potency cannabis and mental health conditions such as anxiety and depression is not incidental, and the shift toward products with dramatically elevated THC concentrations over recent decades has outpaced what most young developing brains can tolerate without consequence. Gen Z has grown up with near-unrestricted access to concentrates, vape cartridges, and edibles that bear little resemblance to the cannabis of prior generations, making direct comparisons across age cohorts scientifically problematic but still clinically instructive.
Cannabis and Anxiety Relief in Real-World Patients: A 45-Day Longitudinal Analysis
A 45-day longitudinal study tracked daily anxiety relief in 416 medical cannabis patients. Cannabis-use days showed larger same-day reductions, but the design limits causal conclusions. Here’s what the data support, and what they don’t.
Secondhand marijuana smoke has fine particles that can cause asthma attacks and … – Instagram
WHY IT MATTERS: If you or someone in your household has asthma or another respiratory condition, exposure to secondhand marijuana smoke in shared spaces like homes or vehicles can trigger serious symptoms even without directly using cannabis. CLINICAL OVERVIEW: Secondhand marijuana smoke contains fine particulate matter that can trigger respiratory inflammation and exacerbate conditions like asthma, making exposure a legitimate public health concern beyond the individual user. Unlike the common assumption that cannabis smoke is less harmful than tobacco smoke, the combustion process produces many of the same irritants and carcinogens regardless of the plant material being burned.
Tennessee sisters fear new hemp law as CBD oils become harder to access – YouTube
WHY IT MATTERS: If state-level hemp restrictions eliminate access to full-spectrum CBD oils, patients with conditions like Dystonia who have found relief with these specific formulations may be left without a viable therapeutic option and no equivalent substitute. CLINICAL OVERVIEW: Dystonia is a neurological movement disorder characterized by sustained or repetitive muscle contractions that cause abnormal postures and significant pain, and some patients have found meaningful symptom relief through full-spectrum CBD formulations that include a range of naturally occurring cannabinoids beyond CBD alone. The endocannabinoid system plays a role in modulating pain signaling, muscle tone, and neurological function, which provides a plausible biological basis for why patients with movement disorders may respond to cannabinoid-based therapies.
MS Senate committee approves one medical marijuana bill, rejects another
WHY IT MATTERS: If Mississippi’s expanded eligibility criteria are signed into law, patients with conditions previously excluded from the state program may finally qualify for legal medical cannabis access through licensed providers. CLINICAL OVERVIEW: Mississippi continues to refine its medical cannabis program through legislative debate, with ongoing questions about which patient populations qualify for access and whether cannabis can be administered in clinical settings like hospitals. Expanding qualifying conditions is a clinically meaningful step, as many patients with legitimate therapeutic needs have historically been excluded from state programs due to overly narrow eligibility criteria.